Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 1201
Gene Symbol: CLN3
CLN3
1.000 Biomarker disease BEFREE In studying a mouse model for Batten disease, we report the presence of an autoantibody to glutamic acid decarboxylase (GAD65) in cln3-knockout mice serum that associates with brain tissue but is not present in sera or brain of normal mice. 12023984 2002
Entrez Id: 1201
Gene Symbol: CLN3
CLN3
1.000 Biomarker disease BEFREE Our findings are evidence that the Cln3-deficient mouse provides a valuable model for studying Batten disease. 10527801 1999
Entrez Id: 1201
Gene Symbol: CLN3
CLN3
1.000 Biomarker disease BEFREE Juvenile neuronal ceroid lipofuscinosis (JNCL), also known as Batten disease, is the most common form of NCLs. 30892110 2019
Entrez Id: 1201
Gene Symbol: CLN3
CLN3
1.000 Biomarker disease MGD Our findings are evidence that the Cln3-deficient mouse provides a valuable model for studying Batten disease. 10527801 1999
Entrez Id: 1201
Gene Symbol: CLN3
CLN3
1.000 Biomarker disease BEFREE In juvenile neuronal ceroid-lipofuscinosis (JNCL), sleep disorders are common. 10913725 2000
Entrez Id: 1201
Gene Symbol: CLN3
CLN3
1.000 Biomarker disease BEFREE Juvenile neuronal ceroid lipofuscinosis (JNCL) is a lysosomal storage disease caused by autosomal recessive mutations in ceroid lipofuscinosis 3 (CLN3). 29964296 2019
Entrez Id: 1201
Gene Symbol: CLN3
CLN3
1.000 Biomarker disease BEFREE Juvenile neuronal ceroid lipofuscinosis (JNCL) is caused by mutations in the <i>CLN3</i> gene. 29470438 2018
Entrez Id: 1201
Gene Symbol: CLN3
CLN3
1.000 Biomarker disease BEFREE We recently cloned a cDNA for CLN3, the gene for juvenile-onset neuronal ceroid lipofuscinosis or Batten disease. 9119403 1997
Entrez Id: 1201
Gene Symbol: CLN3
CLN3
1.000 Biomarker disease BEFREE In the United States, juvenile neuronal ceroid-lipofuscinosis (JNCL) is the most common form of NCL. 9492089 1998
Entrez Id: 1201
Gene Symbol: CLN3
CLN3
1.000 Biomarker disease BEFREE Although CLN3-related oxidative and mitochondrial stresses have been studied in BD, the pathologic mechanism of the disease is not clearly understood. 23524239 2013
Entrez Id: 1201
Gene Symbol: CLN3
CLN3
1.000 Biomarker disease MGD Cln3(Deltaex7/8) knock-in mice with the common JNCL mutation exhibit progressive neurologic disease that begins before birth. 12374761 2002
Entrez Id: 1201
Gene Symbol: CLN3
CLN3
1.000 Biomarker disease BEFREE Batten disease (juvenile-onset neuronal ceroid lipofuscinosis [JNCL]) is an autosomal recessive condition characterized by accumulation of lipopigments (lipofuscin and ceroid) in neurons and other cell types. 9311735 1997
Entrez Id: 1201
Gene Symbol: CLN3
CLN3
1.000 Biomarker disease BEFREE Juvenile neuronal ceroid lipofuscinosis (JNCL) is characterized by severe visual impairment with onset around age 4-8 years, and a developmental course that includes blindness, epilepsy, speech problems, dementia, motor coordination problems, and emotional reactions. 23470553 2013
Entrez Id: 1201
Gene Symbol: CLN3
CLN3
1.000 Biomarker disease BEFREE Initial work has revealed disturbed metabolic pathways in several NCL disorders and most analyses have utilized the infantile (INCL/CLN1) and juvenile (JNCL/CLN3) disease modeling and utilized mainly human and mouse samples. 17045465 2006
Entrez Id: 1201
Gene Symbol: CLN3
CLN3
1.000 Biomarker disease BEFREE Membrane topology of CLN3, the protein underlying Batten disease. 12706816 2003
Entrez Id: 1201
Gene Symbol: CLN3
CLN3
1.000 Biomarker disease BEFREE Farnesylation of Batten disease CLN3 protein. 9151320 1997
Entrez Id: 1201
Gene Symbol: CLN3
CLN3
1.000 Biomarker disease BEFREE To identify candidate biomarkers, we analyzed autopsy brain and matching CSF samples from controls and three genetically distinct NCLs due to deficiencies in palmitoyl protein thioesterase 1 (CLN1 disease), tripeptidyl peptidase 1 (CLN2 disease), and CLN3 protein (CLN3 disease). 28792770 2017
Entrez Id: 1201
Gene Symbol: CLN3
CLN3
1.000 Biomarker disease BEFREE Functional categorization of gene expression changes in the cerebellum of a Cln3-knockout mouse model for Batten disease. 12559844 2003
Entrez Id: 1201
Gene Symbol: CLN3
CLN3
1.000 Biomarker disease BEFREE We propose that defective transport at the lysosomal membrane caused by an absence of functional CLN3 is the primary biochemical defect that results in Batten disease. 14660799 2003
Entrez Id: 1201
Gene Symbol: CLN3
CLN3
1.000 Biomarker disease BEFREE This phenotypic reversal of btn1-Delta can be considered for developing a therapy for Batten disease. 10500178 1999
Entrez Id: 1201
Gene Symbol: CLN3
CLN3
1.000 Biomarker disease BEFREE caspase-dependent/independent apoptosis and autophagy occur caspase-dependent pathways initiate autophagy Golgi fragmentation results from apoptosis ceramide elevation is independent of caspases, and CLN3 blocks all cell death, prevents Golgi fragmentation and elevation of ceramide in JNCL. 16151633 2005
Entrez Id: 1201
Gene Symbol: CLN3
CLN3
1.000 Biomarker disease BEFREE This suggests that the yhc3 delta mutant is a good model to investigate the biological function of human CLN3 gene in mammalian cells and to understand the pathophysiology of juvenile Batten disease. 10384264 1999
Entrez Id: 1201
Gene Symbol: CLN3
CLN3
1.000 Biomarker disease BEFREE Accumulating autofluorescent lysosomal storage material in CLN3 disease, consisting of dolichols, lipids, biometals, and a protein that normally resides in the mitochondria, subunit c of the mitochondrial ATPase, provides evidence that autophagosomal-lysosomal turnover of cellular components is disrupted upon loss of CLN3 protein function. 31783699 2019
Entrez Id: 1201
Gene Symbol: CLN3
CLN3
1.000 Biomarker disease BEFREE Mitochondrial damage results in a reversible increase in lysosomal storage material in lymphoblasts from patients with juvenile neuronal ceroid-lipofuscinosis (Batten Disease). 7668350 1995
Entrez Id: 1201
Gene Symbol: CLN3
CLN3
1.000 Biomarker disease MGD Our results show that CLN3 deficiency alters APCs, which can be a major contributor to the autoimmune response in JNCL. 27101989 2016